{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:17:54Z","timestamp":1778545074334,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["2021XD010"],"award-info":[{"award-number":["2021XD010"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["2020XD010"],"award-info":[{"award-number":["2020XD010"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["YYKJFZJJ2018Y002"],"award-info":[{"award-number":["YYKJFZJJ2018Y002"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["2020XD016"],"award-info":[{"award-number":["2020XD016"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Province Department of Science and Technology","doi-asserted-by":"publisher","award":["2020JQ-463"],"award-info":[{"award-number":["2020JQ-463"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004572","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071932"],"award-info":[{"award-number":["82071932"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901755"],"award-info":[{"award-number":["81901755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023ZD0504500"],"award-info":[{"award-number":["2023ZD0504500"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cjca.2025.08.355","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:14:05Z","timestamp":1758946445000},"page":"2397-2406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy With Residual Obstruction After Alcohol Septal Ablation"],"prefix":"10.1016","volume":"41","author":[{"given":"Juan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjun","family":"Ta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-5727","authenticated-orcid":false,"given":"Liwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.08.355_bib1","first-page":"e533","article-title":"2020 AHA\/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.08.355_bib2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.355_bib3","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.08.355_bib4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jacc.2023.11.013","article-title":"Predictors of repeated septal reduction after alcohol septal ablation in patients with hypertrophic cardiomyopathy","volume":"83","author":"Hiruma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.355_bib5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/eurheartj\/ehv693","article-title":"Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry","volume":"37","author":"Veselka","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.08.355_bib6","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jacc.2011.06.073","article-title":"Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: a multicenter North American Registry","volume":"58","author":"Nagueh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.355_bib7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.5114\/aoms.2020.97969","article-title":"Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry","volume":"16","author":"Veselka","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.cjca.2025.08.355_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacc.2007.04.065","article-title":"Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy","volume":"50","author":"Nagueh","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.355_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jtcvs.2015.03.044","article-title":"Septal myectomy after failed alcohol ablation: does previous percutaneous intervention compromise outcomes of myectomy?","volume":"150","author":"Quintana","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2025.08.355_bib10","first-page":"833","article-title":"Interventions in hypertrophic obstructive cardiomyopathy","volume":"40","author":"Ding","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.355_bib11","first-page":"1096","article-title":"Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: an updated comprehensive review and meta-analysis","volume":"104","author":"da Silva Menezes","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.08.355_bib12","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.4244\/EIJ-D-17-00657","article-title":"Percutaneous intramyocardial septal radiofrequency ablation of hypertrophic obstructive cardiomyopathy: a novel minimally invasive treatment for reduction of outflow tract obstruction","volume":"13","author":"Liu","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cjca.2025.08.355_bib13","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jacc.2018.07.080","article-title":"Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy","volume":"72","author":"Liu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.355_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamacardio.2022.0259","article-title":"Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy","volume":"7","author":"Zhou","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2025.08.355_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/heartjnl-2022-321597","article-title":"Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation","volume":"109","author":"Li","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2025.08.355_bib16","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2025.08.355_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2025.08.355_bib18","first-page":"1457","article-title":"Comparison of percutaneous endocardial septal radiofrequency ablation with alcohol septal ablation in treating hypertrophic obstructive cardiomyopathy","volume":"41","author":"Tian","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.355_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.21037\/acs.2017.05.09","article-title":"Alcohol septal ablation: in which patients and why?","volume":"6","author":"Spirito","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.08.355_bib20","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.124.069378","article-title":"Long-term outcomes after septal reduction therapies in obstructive hypertrophic cardiomyopathy: insights from the SHARE Registry","volume":"150","author":"Maurizi","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.08.355_bib21","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.08.355_bib22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.21037\/acs.2017.05.11","article-title":"Septal myectomy after failed septal alcohol ablation","volume":"6","author":"Quintana","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2025.08.355_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jocs.14072","article-title":"Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction","volume":"34","author":"Zhu","year":"2019","journal-title":"J Card Surg"},{"key":"10.1016\/j.cjca.2025.08.355_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1536\/ihj.20-428","article-title":"Surgical septal myectomy for the treatment of residual left ventricular outflow tract obstruction following failed alcohol septal ablation","volume":"62","author":"Ji","year":"2021","journal-title":"Int Heart J"},{"key":"10.1016\/j.cjca.2025.08.355_bib25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.21037\/jtd-20-2779","article-title":"Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation","volume":"13","author":"Yang","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.cjca.2025.08.355_bib26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/heartjnl-2023-323606","article-title":"Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up","volume":"110","author":"Ta","year":"2024","journal-title":"Heart"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25010517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25010517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:53:38Z","timestamp":1778543618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25010517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0828282X25010517"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.355","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy With Residual Obstruction After Alcohol Septal Ablation","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.335","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}